ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000235999.1	ABT-263 (navitoclax)	Lymphoid neoplasm diffuse large B-cell lymphoma	0.030508108	Resistant
ENSG00000235999.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.001102603	Resistant